To confirm this, immunofluorescence assays were performed with anti-CD4, anti-CD8, and anti-CD3 antibodies on tumor tissue sections obtained from different treatments in a pancreatic cancer subcutaneous tumor mouse model. This evidence concerns the gene CD8A and familial pancreatic carcinoma.